SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-010574
Filing Date
2024-03-19
Accepted
2024-03-19 21:51:35
Documents
2
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1559
2 ex24.htm EX-24 15256
  Complete submission text file 0001493152-24-010574.txt   18339
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Issuer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 152 W. 57TH STREET 4TH FLOOR NEW YORK NY 10019
Business Address
Latkin Jed (Reporting) CIK: 0001554593 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21617 | Film No.: 24766193